Sanara MedTech Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $103.1M | $86.7M | $65.0M | $45.8M | $24.1M |
| Cost of revenue | $7.5M | $8.1M | $7.9M | $6.4M | $2.3M |
| Gross profit | $95.6M | $78.5M | $57.1M | $39.5M | $21.8M |
| Selling, general & administrative | $78.7M | $71.7M | $57.0M | $46.0M | $28.1M |
| Research and development | $5.1M | $2.8M | $4.1M | $3.4M | $558,704 |
| Operating expenses | $88.3M | $77.3M | $61.4M | $52.0M | $29.2M |
| Operating income | $7.3M | $1.3M | -$4.2M | -$12.5M | -$7.4M |
| Interest expense | $6.8M | $3.1M | $475,783 | $284,746 | $711 |
| Pretax income | -$393,124 | -$1.9M | -$4.4M | -$13.9M | -$8.0M |
| Income tax expense | — | $48,380 | — | -$5.8M | — |
| Net income | -$37.6M | -$9.7M | -$4.3M | -$7.9M | -$7.9M |
| Balance Sheet | |||||
| Cash and equivalents | $16.6M | $15.9M | $5.1M | $9.0M | $18.7M |
| Current assets | $33.5M | $33.3M | $19.0M | $20.6M | $24.6M |
| Total assets | $72.9M | $88.1M | $73.9M | $61.0M | $36.4M |
| Current liabilities | $18.6M | $15.3M | $13.8M | $12.8M | $6.0M |
| Total liabilities | $67.0M | $49.2M | $29.3M | $19.3M | $6.2M |
| Total debt | $46.9M | $31.7M | $9.8M | — | — |
| Stockholders' equity | $5.9M | $39.4M | $44.8M | $41.8M | $30.6M |
| Cash Flow Statement | |||||
| Cash from operations | $6.8M | -$23,784 | -$3.2M | -$5.6M | -$4.8M |
| Depreciation and amortization | $3.9M | $4.9M | $456,138 | $407,769 | $220,571 |
| Stock-based compensation | $5.2M | $4.4M | $3.4M | $2.7M | $2.7M |
| Capital expenditure | $4.6M | $205,848 | $265,246 | $147,015 | $171,867 |
| Free cash flow | $2.2M | -$229,632 | -$3.5M | -$5.7M | -$5.0M |
| Impairments | $28.3M | — | — | — | — |
Shares outstanding 9.2M · Free float 30.7%
Annual filing data through FY ended December 31, 2025; float as of July 8, 2026.